Heparan sulfate proteoglycan expression in human lung-cancer cells

作者: Kris Nackaerts , Erik Verbeken , Georges Deneffe , Bernadette Vanderschueren , Maurits Demedts

DOI: 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.0.CO;2-A

关键词:

摘要: Heparan sulfate (HS) functions as a co-factor in several signal-transduction systems that affect cellular growth, differentiation, adhesion and motility. HS, therefore, may also play role the malignant transformation of cells, tumor cell invasiveness formation metastases. To explore this hypothesis, we analyzed expression HS heparan proteoglycan (HSPG) histological sections human lung-cancer tissues assayed for presence HSPGs extracts lines, using panel native HS-, Δ-HS- HSPG (syndecan, glypican, CD44 perlecan) core protein–specific monoclonal antibodies. Compared to normal epithelia, non-small-cell lung carcinomas, particularly poorly differentiated tumors, often expressed reduced amounts major surface–associated (most consistently syndecan-1). or CD44-variant proteins, contrast, were found on all irrespective their differentiation. Perlecan, matrix-associated basement membrane bronchial epithelium, was undetectable invasive bronchogenic carcinomas. Staining reactions squamous-cell cells contact with stroma less areas these tumors. Reactions Δ-HS, however, not reduced, suggesting structural change cells. Poorly adenocarcinomas, yielded strong Δ-HS reactions. Marked differences observed among various carcinoma lines. Our results suggest tumors have markedly altered patterns expression, which contribute phenotype. Int. J. Cancer 74:335–345, 1997. © 1997 Wiley-Liss, Inc.

参考文章(26)
B F Liebersbach, R D Sanderson, Expression of syndecan-1 inhibits cell invasion into type I collagen. Journal of Biological Chemistry. ,vol. 269, pp. 20013- 20019 ,(1994) , 10.1016/S0021-9258(17)32120-8
M Mali, H Andtfolk, H M Miettinen, M Jalkanen, Suppression of tumor cell growth by syndecan-1 ectodomain Journal of Biological Chemistry. ,vol. 269, pp. 27795- 27798 ,(1995) , 10.1016/S0021-9258(18)46853-6
Erik A. Bruyneel, Kris L. Vleminckx, Annick A. Keirsebilck, Geert M. R. Vandenbossche, Joris J. Deman, Marc M. Mareel, Frans M. van Roy, Enlarged Cell-associated Proteoglycans Abolish E-Cadherin Functionality in Invasive Tumor Cells Cancer Research. ,vol. 54, pp. 873- 877 ,(1994)
Guido David, Integral membrane heparan sulfate proteoglycans. The FASEB Journal. ,vol. 7, pp. 1023- 1030 ,(1993) , 10.1096/FASEBJ.7.11.8370471
R V Iozzo, I R Cohen, S Grässel, A D Murdoch, The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochemical Journal. ,vol. 302, pp. 625- 639 ,(1994) , 10.1042/BJ3020625
Helmut Ponta, Wolfgang Rudy, Margot Zöller, Peter Herrlich, Martin Hofmann, Ursula Günthert, Cornelia Tölg, CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Research. ,vol. 51, pp. 5292- 5297 ,(1991)
Walter Birchmeier, Uwe H. Frixen, Jörg H. Schipper, Jürgen Behrens, Klaus Jahnke, Andreas Unger, E-Cadherin Expression in Squamous Cell Carcinomas of Head and Neck: Inverse Correlation with Tumor Dedifferentiation and Lymph Node Metastasis Cancer Research. ,vol. 51, pp. 6328- 6337 ,(1991)
Renato V. Iozzo, David Berd, Alan D. Murdoch, Dario Marchetti, Isabelle R. Cohen, Michael F. Naso, Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Research. ,vol. 54, pp. 5771- 5774 ,(1994)
J Behrens, M M Mareel, F M Van Roy, W Birchmeier, Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. Journal of Cell Biology. ,vol. 108, pp. 2435- 2447 ,(1989) , 10.1083/JCB.108.6.2435